賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白
Recombinant Lysyl Oxidase Like Protein 2 (LOXL2)
LOR2; WS9-14; Lysyl oxidase homolog 2; Lysyl oxidase-related protein 2; Lysyl oxidase-related protein WS9-14
- 編號RPF552Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量13.0kDa
- 實際分子量16kDa(差異分析請參閱說明書)
- 片段與標簽Pro53~Val160 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 95%
- 等電點6.0
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1085 ¥ 2712 ¥ 5424 ¥ 16272 ¥ 40680
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPF552Mu01 | 賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF552Mu01 | 賴氨酰氧化酶樣蛋白2(LOXL2)多克隆抗體 | WB; IHC; ICC; IP. |
| LAF552Mu71 | 賴氨酰氧化酶樣蛋白2(LOXL2)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| SEF552Mu | 賴氨酰氧化酶樣蛋白2(LOXL2)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF552Mu | 賴氨酰氧化酶樣蛋白2(LOXL2)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| BMC Cancer. | Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.12 [Pubmed: 24007603] |
| Current Eye Research | High Glucose Induced Differential Expression of Lysyl Oxidase and Its Isoform in ARPE-19 Cells [Pubmed: 22966818] |
| Curr Eye Res | Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-? Levels and LOXL1 Genotype in Pseudoexfoliation [Pubmed:27116380] |
| BMC Cancer | Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study [Pubmed:29558905] |
| Laryngoscope | Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma [Pubmed: 31219623] |
留言咨詢
